GRACE ANDRADE: Open Payments
NPI 1285153221 · ODESSA, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$132 in 7 payments from 6 companies in 2025. Trend: 2023 $1,037 · 2024 $821 · 2025 $132
Food & beverage: $132
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 2 | $35 |
| Abbott Laboratories | 1 | $26 |
| Xeris Pharmaceuticals, Inc. | 1 | $23 |
| Lilly USA, LLC | 1 | $17 |
| GlaxoSmithKline, LLC. | 1 | $16 |
| Corcept Therapeutics | 1 | $15 |
Products named: PROCLAIM, GVOKE HYPOPEN, Saxenda, MOUNJARO, TRELEGY ELLIPTA, Korlym, Rybelsus.
Industry payments across TX — which companies pay providers there.
